Preclinical effects of APOE ζ4 on cerebrospinal fluid Aβ42 concentrations
Gespeichert in:
| Veröffentlicht in: | Alzheimer's research & therapy 2017-10, Vol.9 (1) |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 1 |
| container_start_page | |
| container_title | Alzheimer's research & therapy |
| container_volume | 9 |
| creator | Lautner, Ronald Insel, Philip S Skillb?ck, Tobias Olsson, Bob Land?n, Mikael Frisoni, Giovanni B Herukka, Sanna-Kaisa Hampel, Harald Wallin, Anders Minthon, Lennart Hansson, Oskar Blennow, Kaj Mattsson, Niklas Zetterberg, Henrik |
| description | |
| doi_str_mv | 10.1186/s13195-017-0313-3 |
| format | Article |
| fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A511358305</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A511358305</galeid><sourcerecordid>A511358305</sourcerecordid><originalsourceid>FETCH-LOGICAL-g985-2811ec18a99109bdc2365ebfb99ad12d12469f11d190b07d462ac3b59cf310c93</originalsourceid><addsrcrecordid>eNptj89KAzEQxoMoWKsP4C0geEvNbDa7yXEp9Q8W2kPvJZtN2kiayGb7Yh58jD6TQT2sIDMww_D7Pr5B6BboDEBUDwkYSE4o1IQyYISdoQnUXBAJkp2P9kt0ldIbpVVViHKCXte90d4Fp5XHxlqjh4Sjxc16tcCnzxLHgLXpTdvH9O5Chqw_ug43p4-ywDoGbcLQq8HFkK7RhVU-mZvfOUWbx8Vm_kyWq6eXebMkOyk4KQSA0SCUlEBl2-mCVdy0tpVSdVDkLitpATqQtKV1V1aF0qzlUlsGVEs2RXc_tjvlzdYFG3MAfXBJbxsOwLhglGdq9g-VqzMHl3Mb6_L9j-B-JNgb5Yd9iv74_doY_ALkTGud</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Preclinical effects of APOE ζ4 on cerebrospinal fluid Aβ42 concentrations</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>SpringerNature Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>PubMed Central</source><creator>Lautner, Ronald ; Insel, Philip S ; Skillb?ck, Tobias ; Olsson, Bob ; Land?n, Mikael ; Frisoni, Giovanni B ; Herukka, Sanna-Kaisa ; Hampel, Harald ; Wallin, Anders ; Minthon, Lennart ; Hansson, Oskar ; Blennow, Kaj ; Mattsson, Niklas ; Zetterberg, Henrik</creator><creatorcontrib>Lautner, Ronald ; Insel, Philip S ; Skillb?ck, Tobias ; Olsson, Bob ; Land?n, Mikael ; Frisoni, Giovanni B ; Herukka, Sanna-Kaisa ; Hampel, Harald ; Wallin, Anders ; Minthon, Lennart ; Hansson, Oskar ; Blennow, Kaj ; Mattsson, Niklas ; Zetterberg, Henrik</creatorcontrib><identifier>ISSN: 1758-9193</identifier><identifier>EISSN: 1758-9193</identifier><identifier>DOI: 10.1186/s13195-017-0313-3</identifier><language>eng</language><publisher>BioMed Central Ltd</publisher><subject>Alzheimer's disease ; Amyloid beta-protein ; Apolipoproteins ; Cerebrospinal fluid ; Genetic aspects ; Health aspects ; Risk factors</subject><ispartof>Alzheimer's research & therapy, 2017-10, Vol.9 (1)</ispartof><rights>COPYRIGHT 2017 BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Lautner, Ronald</creatorcontrib><creatorcontrib>Insel, Philip S</creatorcontrib><creatorcontrib>Skillb?ck, Tobias</creatorcontrib><creatorcontrib>Olsson, Bob</creatorcontrib><creatorcontrib>Land?n, Mikael</creatorcontrib><creatorcontrib>Frisoni, Giovanni B</creatorcontrib><creatorcontrib>Herukka, Sanna-Kaisa</creatorcontrib><creatorcontrib>Hampel, Harald</creatorcontrib><creatorcontrib>Wallin, Anders</creatorcontrib><creatorcontrib>Minthon, Lennart</creatorcontrib><creatorcontrib>Hansson, Oskar</creatorcontrib><creatorcontrib>Blennow, Kaj</creatorcontrib><creatorcontrib>Mattsson, Niklas</creatorcontrib><creatorcontrib>Zetterberg, Henrik</creatorcontrib><title>Preclinical effects of APOE ζ4 on cerebrospinal fluid Aβ42 concentrations</title><title>Alzheimer's research & therapy</title><subject>Alzheimer's disease</subject><subject>Amyloid beta-protein</subject><subject>Apolipoproteins</subject><subject>Cerebrospinal fluid</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Risk factors</subject><issn>1758-9193</issn><issn>1758-9193</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptj89KAzEQxoMoWKsP4C0geEvNbDa7yXEp9Q8W2kPvJZtN2kiayGb7Yh58jD6TQT2sIDMww_D7Pr5B6BboDEBUDwkYSE4o1IQyYISdoQnUXBAJkp2P9kt0ldIbpVVViHKCXte90d4Fp5XHxlqjh4Sjxc16tcCnzxLHgLXpTdvH9O5Chqw_ug43p4-ywDoGbcLQq8HFkK7RhVU-mZvfOUWbx8Vm_kyWq6eXebMkOyk4KQSA0SCUlEBl2-mCVdy0tpVSdVDkLitpATqQtKV1V1aF0qzlUlsGVEs2RXc_tjvlzdYFG3MAfXBJbxsOwLhglGdq9g-VqzMHl3Mb6_L9j-B-JNgb5Yd9iv74_doY_ALkTGud</recordid><startdate>20171023</startdate><enddate>20171023</enddate><creator>Lautner, Ronald</creator><creator>Insel, Philip S</creator><creator>Skillb?ck, Tobias</creator><creator>Olsson, Bob</creator><creator>Land?n, Mikael</creator><creator>Frisoni, Giovanni B</creator><creator>Herukka, Sanna-Kaisa</creator><creator>Hampel, Harald</creator><creator>Wallin, Anders</creator><creator>Minthon, Lennart</creator><creator>Hansson, Oskar</creator><creator>Blennow, Kaj</creator><creator>Mattsson, Niklas</creator><creator>Zetterberg, Henrik</creator><general>BioMed Central Ltd</general><scope/></search><sort><creationdate>20171023</creationdate><title>Preclinical effects of APOE ζ4 on cerebrospinal fluid Aβ42 concentrations</title><author>Lautner, Ronald ; Insel, Philip S ; Skillb?ck, Tobias ; Olsson, Bob ; Land?n, Mikael ; Frisoni, Giovanni B ; Herukka, Sanna-Kaisa ; Hampel, Harald ; Wallin, Anders ; Minthon, Lennart ; Hansson, Oskar ; Blennow, Kaj ; Mattsson, Niklas ; Zetterberg, Henrik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g985-2811ec18a99109bdc2365ebfb99ad12d12469f11d190b07d462ac3b59cf310c93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Alzheimer's disease</topic><topic>Amyloid beta-protein</topic><topic>Apolipoproteins</topic><topic>Cerebrospinal fluid</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lautner, Ronald</creatorcontrib><creatorcontrib>Insel, Philip S</creatorcontrib><creatorcontrib>Skillb?ck, Tobias</creatorcontrib><creatorcontrib>Olsson, Bob</creatorcontrib><creatorcontrib>Land?n, Mikael</creatorcontrib><creatorcontrib>Frisoni, Giovanni B</creatorcontrib><creatorcontrib>Herukka, Sanna-Kaisa</creatorcontrib><creatorcontrib>Hampel, Harald</creatorcontrib><creatorcontrib>Wallin, Anders</creatorcontrib><creatorcontrib>Minthon, Lennart</creatorcontrib><creatorcontrib>Hansson, Oskar</creatorcontrib><creatorcontrib>Blennow, Kaj</creatorcontrib><creatorcontrib>Mattsson, Niklas</creatorcontrib><creatorcontrib>Zetterberg, Henrik</creatorcontrib><jtitle>Alzheimer's research & therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lautner, Ronald</au><au>Insel, Philip S</au><au>Skillb?ck, Tobias</au><au>Olsson, Bob</au><au>Land?n, Mikael</au><au>Frisoni, Giovanni B</au><au>Herukka, Sanna-Kaisa</au><au>Hampel, Harald</au><au>Wallin, Anders</au><au>Minthon, Lennart</au><au>Hansson, Oskar</au><au>Blennow, Kaj</au><au>Mattsson, Niklas</au><au>Zetterberg, Henrik</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preclinical effects of APOE ζ4 on cerebrospinal fluid Aβ42 concentrations</atitle><jtitle>Alzheimer's research & therapy</jtitle><date>2017-10-23</date><risdate>2017</risdate><volume>9</volume><issue>1</issue><issn>1758-9193</issn><eissn>1758-9193</eissn><pub>BioMed Central Ltd</pub><doi>10.1186/s13195-017-0313-3</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1758-9193 |
| ispartof | Alzheimer's research & therapy, 2017-10, Vol.9 (1) |
| issn | 1758-9193 1758-9193 |
| language | eng |
| recordid | cdi_gale_infotracmisc_A511358305 |
| source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; SpringerNature Journals; PubMed Central Open Access; Springer Nature OA Free Journals; PubMed Central |
| subjects | Alzheimer's disease Amyloid beta-protein Apolipoproteins Cerebrospinal fluid Genetic aspects Health aspects Risk factors |
| title | Preclinical effects of APOE ζ4 on cerebrospinal fluid Aβ42 concentrations |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T17%3A18%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preclinical%20effects%20of%20APOE%20%CE%B64%20on%20cerebrospinal%20fluid%20A%CE%B242%20concentrations&rft.jtitle=Alzheimer's%20research%20&%20therapy&rft.au=Lautner,%20Ronald&rft.date=2017-10-23&rft.volume=9&rft.issue=1&rft.issn=1758-9193&rft.eissn=1758-9193&rft_id=info:doi/10.1186/s13195-017-0313-3&rft_dat=%3Cgale%3EA511358305%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A511358305&rfr_iscdi=true |